logo
Select company
Select metric
13.5Enterprise Value over Free Cash Flow
VS
Market
72
Sector
78
Industry
88
History
100
$ 0.41Close
$ 0.28 - $ 2.82 52-Week Range
Ticker Information

Ticker

HBIO

Company Name

HARVARD BIOSCIENCE INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

HARVARD BIOSCIENCE INC - Enterprise Value over Free Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HBIO - EV/FCF Historical data
DateEnterprise ValueEnterprise Value over Free Cash FlowFree Cash Flow
6/30/2025$ 55.75M13.5$ 4.13M
3/31/2025$ 53.21M0$ -203K
12/31/2024$ 67.79M0$ -1.82M
9/30/2024$ 152.09M0$ -132K
6/30/2024$ 172.41M28.9$ 5.96M
3/31/2024$ 199.97M18.5$ 10.81M
12/31/2023$ 234.22M19.99$ 11.72M
9/30/2023$ 221.37M19.75$ 11.21M
6/30/2023$ 232.99M32.03$ 7.27M
3/31/2023$ 283.17M78.51$ 3.61M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HARVARD BIOSCIENCE INC's latest trailing twelve months (TTM) EV/FCF stands at 25.69.
  • Over the past 5 years, HARVARD BIOSCIENCE INC's average EV/FCF has been 392.18.
  • The median EV/FCF for HARVARD BIOSCIENCE INC during this period was 32.03
  • HARVARD BIOSCIENCE INC reached its highest EV/FCF over the past 5 years at 4.55K.
  • The lowest EV/FCF recorded by HARVARD BIOSCIENCE INC in the same timeframe 13.5

HARVARD BIOSCIENCE INC's EV/FCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EV/FCF Benchmarks
CompanyEV/FCF
RVP : RETRACTABLE TECHNOLOGIES INC -NXGL : NEXGEL INC -ADAP : ADAPTIMMUNE THERAPEUTICS PLC -NSYS : NORTECH SYSTEMS INC -BNGO : BIONANO GENOMICS INC -AYTU : AYTU BIOPHARMA INC -IRIX : IRIDEX CORP -COSM : COSMOS HEALTH INC -NEPH : NEPHROS INC 13.42EKSO : EKSO BIONICS HOLDINGS INC -

Definition of Enterprise Value over Free Cash Flow

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
EV / FCF
(=) EV/FCF
EV/FCF for HARVARD BIOSCIENCE INC is calculated as follows: EV [ $ 193.59M ] / FCF [ $ 7.54M ]
(=) EV/FCF [ 25.69 ]

HBIO - Enterprise Value over Free Cash Flow, Last 5 years

13.5

Minimum

Jun 30, 2025

4.55K

Maximum

Dec 31, 2021

392.18

Average

32.03

Median

EV/FCF Benchmark Analysis

The chart above depicts the distribution of EV/FCF for companies in the Total Stock Market. The average EV/FCF of the companies is 23.45 with a standard deviation of 16.13.
The following table provides additional summary stats:
EV/FCF in the Market:
filtered constituents2.2K
min0.05
max77.98
average23.45
median19.08
std16.13